PMC:7402624 / 75215-75599 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T554","span":{"begin":169,"end":171},"obj":"Body_part"},{"id":"T555","span":{"begin":182,"end":187},"obj":"Body_part"},{"id":"T556","span":{"begin":219,"end":224},"obj":"Body_part"},{"id":"T557","span":{"begin":256,"end":261},"obj":"Body_part"},{"id":"T558","span":{"begin":263,"end":266},"obj":"Body_part"},{"id":"T559","span":{"begin":300,"end":305},"obj":"Body_part"},{"id":"T560","span":{"begin":307,"end":310},"obj":"Body_part"},{"id":"T561","span":{"begin":344,"end":349},"obj":"Body_part"}],"attributes":[{"id":"A554","pred":"fma_id","subj":"T554","obj":"http://purl.org/sig/ont/fma/fma84371"},{"id":"A555","pred":"fma_id","subj":"T555","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A556","pred":"fma_id","subj":"T556","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A557","pred":"fma_id","subj":"T557","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A558","pred":"fma_id","subj":"T558","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A559","pred":"fma_id","subj":"T559","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A560","pred":"fma_id","subj":"T560","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A561","pred":"fma_id","subj":"T561","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"To define COVID-19 patients with low or absent immune responses, classified as immunotype 3, the intersection of the bottom 50% of 5 different flow parameters was used: PB as % of B cells, KI67+ as % of non-naïve CD4 T cells, KI67+ as % of non-naïve CD8 T cells, HLA-DR+CD38+ as % of non-naïve CD4 T cells, HLA-DR+CD38+ as % of non-naïve CD8 T cells—graphically displayed in fig. S10."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2182","span":{"begin":213,"end":216},"obj":"Gene"},{"id":"2183","span":{"begin":250,"end":253},"obj":"Gene"},{"id":"2184","span":{"begin":270,"end":274},"obj":"Gene"},{"id":"2185","span":{"begin":294,"end":297},"obj":"Gene"},{"id":"2186","span":{"begin":314,"end":318},"obj":"Gene"},{"id":"2187","span":{"begin":338,"end":341},"obj":"Gene"},{"id":"2188","span":{"begin":19,"end":27},"obj":"Species"},{"id":"2189","span":{"begin":10,"end":18},"obj":"Disease"}],"attributes":[{"id":"A2182","pred":"tao:has_database_id","subj":"2182","obj":"Gene:920"},{"id":"A2183","pred":"tao:has_database_id","subj":"2183","obj":"Gene:925"},{"id":"A2184","pred":"tao:has_database_id","subj":"2184","obj":"Gene:952"},{"id":"A2185","pred":"tao:has_database_id","subj":"2185","obj":"Gene:920"},{"id":"A2186","pred":"tao:has_database_id","subj":"2186","obj":"Gene:952"},{"id":"A2187","pred":"tao:has_database_id","subj":"2187","obj":"Gene:925"},{"id":"A2188","pred":"tao:has_database_id","subj":"2188","obj":"Tax:9606"},{"id":"A2189","pred":"tao:has_database_id","subj":"2189","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"To define COVID-19 patients with low or absent immune responses, classified as immunotype 3, the intersection of the bottom 50% of 5 different flow parameters was used: PB as % of B cells, KI67+ as % of non-naïve CD4 T cells, KI67+ as % of non-naïve CD8 T cells, HLA-DR+CD38+ as % of non-naïve CD4 T cells, HLA-DR+CD38+ as % of non-naïve CD8 T cells—graphically displayed in fig. S10."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T440","span":{"begin":10,"end":18},"obj":"Disease"},{"id":"T441","span":{"begin":169,"end":171},"obj":"Disease"}],"attributes":[{"id":"A440","pred":"mondo_id","subj":"T440","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A441","pred":"mondo_id","subj":"T441","obj":"http://purl.obolibrary.org/obo/MONDO_0019035"}],"text":"To define COVID-19 patients with low or absent immune responses, classified as immunotype 3, the intersection of the bottom 50% of 5 different flow parameters was used: PB as % of B cells, KI67+ as % of non-naïve CD4 T cells, KI67+ as % of non-naïve CD8 T cells, HLA-DR+CD38+ as % of non-naïve CD4 T cells, HLA-DR+CD38+ as % of non-naïve CD8 T cells—graphically displayed in fig. S10."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1058","span":{"begin":180,"end":187},"obj":"http://purl.obolibrary.org/obo/CL_0000236"},{"id":"T1059","span":{"begin":207,"end":224},"obj":"http://purl.obolibrary.org/obo/CL_0000895"},{"id":"T1060","span":{"begin":250,"end":253},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"},{"id":"T1061","span":{"begin":254,"end":261},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T1062","span":{"begin":270,"end":274},"obj":"http://purl.obolibrary.org/obo/PR_000001408"},{"id":"T1063","span":{"begin":288,"end":305},"obj":"http://purl.obolibrary.org/obo/CL_0000895"},{"id":"T1064","span":{"begin":314,"end":318},"obj":"http://purl.obolibrary.org/obo/PR_000001408"},{"id":"T1065","span":{"begin":338,"end":341},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"},{"id":"T1066","span":{"begin":342,"end":349},"obj":"http://purl.obolibrary.org/obo/CL_0000084"}],"text":"To define COVID-19 patients with low or absent immune responses, classified as immunotype 3, the intersection of the bottom 50% of 5 different flow parameters was used: PB as % of B cells, KI67+ as % of non-naïve CD4 T cells, KI67+ as % of non-naïve CD8 T cells, HLA-DR+CD38+ as % of non-naïve CD4 T cells, HLA-DR+CD38+ as % of non-naïve CD8 T cells—graphically displayed in fig. S10."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T84888","span":{"begin":169,"end":171},"obj":"Chemical"},{"id":"T53019","span":{"begin":267,"end":269},"obj":"Chemical"},{"id":"T74745","span":{"begin":311,"end":313},"obj":"Chemical"}],"attributes":[{"id":"A11724","pred":"chebi_id","subj":"T84888","obj":"http://purl.obolibrary.org/obo/CHEBI_53319"},{"id":"A1015","pred":"chebi_id","subj":"T84888","obj":"http://purl.obolibrary.org/obo/CHEBI_60686"},{"id":"A37252","pred":"chebi_id","subj":"T53019","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"},{"id":"A87424","pred":"chebi_id","subj":"T74745","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"}],"text":"To define COVID-19 patients with low or absent immune responses, classified as immunotype 3, the intersection of the bottom 50% of 5 different flow parameters was used: PB as % of B cells, KI67+ as % of non-naïve CD4 T cells, KI67+ as % of non-naïve CD8 T cells, HLA-DR+CD38+ as % of non-naïve CD4 T cells, HLA-DR+CD38+ as % of non-naïve CD8 T cells—graphically displayed in fig. S10."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T136","span":{"begin":47,"end":63},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"To define COVID-19 patients with low or absent immune responses, classified as immunotype 3, the intersection of the bottom 50% of 5 different flow parameters was used: PB as % of B cells, KI67+ as % of non-naïve CD4 T cells, KI67+ as % of non-naïve CD8 T cells, HLA-DR+CD38+ as % of non-naïve CD4 T cells, HLA-DR+CD38+ as % of non-naïve CD8 T cells—graphically displayed in fig. S10."}

{"project":"LitCovid-sentences","denotations":[{"id":"T466","span":{"begin":0,"end":384},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"To define COVID-19 patients with low or absent immune responses, classified as immunotype 3, the intersection of the bottom 50% of 5 different flow parameters was used: PB as % of B cells, KI67+ as % of non-naïve CD4 T cells, KI67+ as % of non-naïve CD8 T cells, HLA-DR+CD38+ as % of non-naïve CD4 T cells, HLA-DR+CD38+ as % of non-naïve CD8 T cells—graphically displayed in fig. S10."}